Colorectal cancer trials in China

In China 616 Also abroad 1941

616 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases
Where
Hangzhou
Age
18 years and over
People
120
Run by
Bing Xia
See details and how to joinNCT07875465
Phase 1Not yet taking people in China
Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation
Where
Beijing, Hangzhou
Age
18 years to 75 years
People
66
Run by
Neowise Biotechnology
See details and how to joinNCT07875920
Phase 2Taking people
A Study of YL202 in Patients With Advanced Solid Tumors
Where
Changsha
Age
18 years and over
People
100
Run by
MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07202364
No phaseNot yet taking people in China
A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) Combined With Cetuximab and mFOLFIRI Regimen as First-Line Treatment for Recurrent or Metastatic Colorectal Cancer
Where
Nanjing
Age
18 years to 75 years
People
55
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07874438
Phase 1/2Taking people
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Where
Beijing, Jinan, Shanghai, Suzhou
Age
18 years and over
People
554 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00
Phase 2Taking people
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
Where
Jinan
Age
18 years to 75 years
People
35
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT06778382
Phase 3Taking people
FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)
Where
Shanghai
Age
18 years to 75 years
People
198
Run by
Fudan University
See details and how to joinNCT07815834
Phase 3Taking people
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Where
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Meizhou, Mianyang, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Wuhan, Xiamen
Age
18 years and over
People
800 worldwide
Run by
Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00
Phase 2Not yet taking people in China
A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer
Where
Wuhan
Age
18 years to 75 years
People
144
Run by
Tao Zhang
See details and how to joinNCT07847229
Phase 3Taking people
Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.
Where
Guangzhou
Age
18 years and over
People
608
Run by
Taizhou Mabtech Pharmaceutical Co.,Ltd
See details and how to joinNCT07595276
No phaseNot yet taking people in China
A Clinical Study on the Synergistic Effects of Zhen-Qi-Jie-Du Granules in Palliative Care for Advanced Colorectal Cancer
Where
Nanjing
Age
18 years to 80 years
People
1,540
Run by
Jiangsu Famous Medical Technology Co., Ltd.
See details and how to joinNCT07854405
Phase 2Taking people
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
Where
Fuzhou
Age
18 years to 75 years
People
35
Run by
Fujian Cancer Hospital
See details and how to joinNCT06788171
Early phase 1Taking people
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Where
Nanjing
Age
18 years and over
People
15
Run by
Base Therapeutics (Shanghai) Co., Ltd.
See details and how to joinNCT07166263
No phaseTaking people
A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)
Where
Guangdong
Age
18 years to 75 years
People
30
Run by
Jie Yuan，MD
See details and how to joinNCT07850882
No phaseTaking people
Tamsulosin for Early Catheter Removal After Rectal Cancer Surgery
Where
Changchun, Harbin
People
1,545
Run by
The First Hospital of Jilin University
See details and how to joinNCT07346586
Phase 2/3Taking people
Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)
Where
Guangzhou
Age
18 years to 75 years
People
430
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06958432
Phase 1/2Not yet taking people in China
TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has Spread
Where
Beijing, Changsha, Foshan, Harbin, Lanzhou, Lishui, Nanjing, Nanning, Shanghai, Tianjin, Wuhan, Yantai, Zhengzhou
Age
18 years to 75 years
People
64
Run by
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT07844187
Phase 1/2Enrolling by invitation
XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation
Where
Beijing
Age
18 years to 75 years
People
102
Run by
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT06936527
Phase 2Taking people
Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer
Where
Chongqing
Age
18 years to 80 years
People
70
Run by
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07840677
Phase 2Taking people
ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer
Where
Shanghai
Age
18 years to 75 years
People
23
Run by
Fudan University
See details and how to joinNCT07841236
Phase 3Taking people
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
Where
Hangzhou
Age
18 years and over
People
108
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT05752136
Phase 2Taking people
FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis
Where
Changzhou
Age
18 years to 75 years
People
30
Run by
Hua Jiang
See details and how to joinNCT06801665
Phase 2Taking people
Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial
Where
Guangzhou
Age
18 years to 75 years
People
160
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT07722754
Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Changsha, Chongqing, Guangzhou, Hangzhou, Hefei, Shanghai, Shenyang, Wuhan, Xi'an, Zhengzhou
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 1/2Taking people
A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.
Where
Beijing, Changchun, Changsha, Chongqing, Foshan, Guangzhou, Harbin, Jingzhou, Lanzhou, Lishui, Nanchang, Nanjing, Nanning, Qiqihar, Shanghai, Shenyang, Tianjin, Ürümqi, Wuhan, Xi'an, Xi’an, Zhengzhou, Zunyi
Age
18 years to 75 years
People
71
Run by
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07653685